Key takeaways:
- Eight Sleep secured $100 million in funding from major investors and sports figures to advance its AI-powered sleep technology.
- The company plans to enter the medical space, beginning with solutions for menopausal sleep disturbances and obstructive sleep apnea.
- Its Pod device already adjusts temperature, body elevation, and soundscapes based on biometrics, with $500 million in sales to date.
- A new Hot Flash Mode targets menopause-related symptoms.
- Eight Sleep aims to seek FDA approval for its medical applications.
Eight Sleep has raised $100 million in new funding to accelerate the company’s vision of transforming the bed into an artificial intelligence (AI)-powered sleep optimization and preventive health device. The round included participation from HSG, Valor Equity Partners, Atreides, Founders Fund, Y Combinator, and sports figures, including Charles Leclerc (Ferrari F1 Driver) and Zak Brown (CEO of McLaren F1).
Its latest Pod, Pod 5, adjusts temperature, elevates the body, and plays integrated soundscapes based on the user’s sleep stages, biometrics, and environment, according to Eight Sleep, which has surpassed $500 million in Pod sales. The company’s full portfolio includes hardware, software, AI, and supplements.
“Eight Sleep has developed a turn-key solution for sleep and health optimization: hardware, software, AI, and consumer goods that dynamically adjust around each person’s needs,” says Matteo Franceschetti, co‑founder and CEO of Eight Sleep, in a release. “This new funding enables us to accelerate the deployment of AI for sleep optimization, expand into medical applications like menopausal sleep and sleep apnea, and bring our technology to millions of people around the world.”
Eight Sleep Plans to Enter the Medical Space
The funding will support Eight Sleep’s entry into the medical space. Building on the Pod’s monitoring capabilities, which include tracking cardiovascular and respiratory patterns, the company is developing AI-powered solutions for medical sleep challenges, starting with menopausal sleep and sleep apnea.
Eight Sleep recently launched Hot Flash Mode, a feature that uses dynamic cooling to provide relief from menopause-related symptoms. Next, the company will develop intelligent interventions for sleep apnea using the Pod’s contactless biometric monitoring and real-time actuations.
It is targeting Food and Drug Administration approval for certain applications.
AI ‘Sleep Agent’ to Model Outcomes
Eight Sleep will also put the funding toward its AI roadmap, starting with the development of a “Sleep Agent.” The Sleep Agent will interpret biometric data and simulate thousands of digital twins per user, allowing it to predict outcomes through advanced modeling. The Sleep Agent can then intelligently adjust variables like temperature, elevation, and bedtime routines to optimize recovery on a nightly basis.
This builds on the company’s existing Autopilot feature, which makes nightly adjustments based on user behavior and biofeedback.
“We’re creating digital twins of your sleep physiology to simulate, test, and personalize your recovery before you even close your eyes,” Franceschetti says. “This is the next frontier: AI that doesn’t just track you; it understands and adapts to you in real time.”
